Delivery Order SPE2DB20D3103-SPE2DB24FL8J0
Award Date 12/8/23
Potential Completion Date 12/11/23
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,852.50 to provide 4,563,816,290 units of THROMBIN-JMI 20,000 unit vials. The contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation indicated. This delivery order is issued under an existing...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $4,180.74, is for the delivery of 5,000 unit vials of the drug Thrombin-JMI, a topical hemostatic agent used to control bleeding. The contract is a firm fixed price, full and open competition award with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB20D3103) with a Ceiling Value of $9,633.40. The contract is for the supply of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price arrangement with an Ultimate Completion Date of October 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 20,000 unit vials of Thrombin-JMI, a medical product. It is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $14,373.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the drug Thrombin-JMI, which is used for various medical applications. The contract is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of January 22, 2025. This contract award is part of a larger...
- This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a major defense agency responsible for logistics support to the U.S. military. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on September 22, 2023 with a ceiling value of $6,595.68 and a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Thrombin-JMI 20,000 unit vials valued at $6,276.96. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ1BQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $2,346.50 firm fixed price delivery order is for the supply of 20,000 unit vials of the pharmaceutical product Thrombin-JMI. The contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp, acting as the prime contractor, will...
- This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order valued at $18,754.65 for the supply of 20,000 unit vials of THROMBIN-JMI, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...